These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2479337)

  • 21. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
    Linch DC; Devereux S; Addison IE
    Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of recombinant human granulocyte colony-stimulating factor on white blood cell count and neutrophil functions in patients with malignant lymphoma].
    Ashida T; Ishikawa H; Urase F; Satoh M; Tsubaki K; Horiuchi A
    Rinsho Ketsueki; 1989 Oct; 30(10):1778-82. PubMed ID: 2480462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
    Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
    Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
    Gabrilove JL; Jakubowski A; Fain K; Grous J; Scher H; Sternberg C; Yagoda A; Clarkson B; Bonilla MA; Oettgen HF
    J Clin Invest; 1988 Oct; 82(4):1454-61. PubMed ID: 2459163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
    Devereaux S; Linch DC; Gribben JG; McMillan A; Patterson K; Goldstone AH
    Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outline of clinical studies on recombinant human granulocyte colony stimulating factor (KRN 8601) in Japan.
    Kaneko T; Takaku F; Ogawa M
    Tokai J Exp Clin Med; 1991 Mar; 16(1):51-61. PubMed ID: 1723550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
    Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA
    Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.
    Grigg A; Begley CG; Juttner CA; Szer J; To LB; Maher D; McGrath KM; Morstyn G; Fox RM; Sheridan WP
    Bone Marrow Transplant; 1993; 11 Suppl 2():23-9. PubMed ID: 8334435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
    Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
    Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.
    Masaoka T; Takaku F; Kato S; Moriyama Y; Kodera Y; Kanamaru A; Shimosaka A; Shibata H; Nakamura H
    Exp Hematol; 1989 Nov; 17(10):1047-50. PubMed ID: 2478381
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.
    Logan TF; Gooding W; Kirkwood JM; Shadduck RK
    Exp Hematol; 1996 Jan; 24(1):49-53. PubMed ID: 8536792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Granulocyte colony stimulating factor for bone marrow transplantation].
    Masaoka T
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3543-9. PubMed ID: 2479338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial.
    Ganser A; Völkers B; Greher J; Walther F; Hoelzer D
    Onkologie; 1988 Feb; 11(1):53-5. PubMed ID: 3283627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant human granulocyte colony-stimulating factor (G-CSF)].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):541-9. PubMed ID: 7680849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.
    Morstyn G; Campbell L; Lieschke G; Layton JE; Maher D; O'Connor M; Green M; Sheridan W; Vincent M; Alton K
    J Clin Oncol; 1989 Oct; 7(10):1554-62. PubMed ID: 2789274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor.
    Lieschke GJ; Cebon J; Morstyn G
    Blood; 1989 Dec; 74(8):2634-43. PubMed ID: 2684297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.